We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
Top Ranked Value Stocks to Buy for March 26th
Here are three stocks with buy rank and strong value characteristics for investors to consider today, March 26th:
Blue Capital Reinsurance Holdings Ltd. : This provider of reinsurance in the property catastrophe market has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 7.4% over the last 60 days.
Blue Capital Reinsurance Holdings Ltd. Price and Consensus
Blue Capital Reinsurance Holdings Ltd. price-consensus-chart | Blue Capital Reinsurance Holdings Ltd. Quote
Blue Capital has a price-to-earnings ratio (P/E) of 8.97 compared with 24.20 for the industry. The company possesses a Value Score of B.
Blue Capital Reinsurance Holdings Ltd. PE Ratio (TTM)
Blue Capital Reinsurance Holdings Ltd. pe-ratio-ttm | Blue Capital Reinsurance Holdings Ltd. Quote
Celgene Corporation : This biopharmaceutical company has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 3.5% over the last 60 days.
Celgene Corporation Price and Consensus
Celgene Corporation price-consensus-chart | Celgene Corporation Quote
Celgene has a price-to-earnings ratio (P/E) of 8.20 compared with 9.50 for the industry. The company possesses a Value Score of B.
Celgene Corporation PE Ratio (TTM)
Celgene Corporation pe-ratio-ttm | Celgene Corporation Quote
PPDAI Group Inc. : This investment holding company has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 2.1% over the last 60 days.
PPDAI Group Inc. Sponsored ADR Price and Consensus
PPDAI Group Inc. Sponsored ADR price-consensus-chart | PPDAI Group Inc. Sponsored ADR Quote
PPDAI has a price-to-earnings ratio (P/E) of 4.15 compared with 5.10 for the industry. The company possesses a Value Score of A.
PPDAI Group Inc. Sponsored ADR PE Ratio (TTM)
PPDAI Group Inc. Sponsored ADR pe-ratio-ttm | PPDAI Group Inc. Sponsored ADR Quote
See the full list of top ranked stocks here
Learn more about the Value score and how it is calculated here.
Is Your Investment Advisor Fumbling Your Financial Future?
See how you can more effectively safeguard your retirement with a new Special Report, “4 Warning Signs Your Investment Advisor Might Be Sabotaging Your Financial Future.”
Click to get it free >>